Bloodstock editor Joe Nevills selects the top first-year and all-weather value sires standing for $20,000 or less in 2026 ...

Patients with treatment-naïve chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia (SLL) who received pirtobrutinib (Jaypirca; Eli Lilly) monotherapy showed an 80% reduction in progression ...

The trial of former elementary school teacher Jordan Henderson opened with remarks from prosecutors and his defense attorney.

With its long, uninterrupted blue runs, family-friendly French resort Les Deux Alpes is ideal for beginner skiers — as well ...

Azacitidine plus venetoclax (Venclexta) demonstrated significantly improved event-free survival (EFS) vs intensive induction chemotherapy in patients with acute myeloid leukemia (AML), according to ...

Macquarie Tax-Free USA Fund returned 3.64% in 3Q25, outperforming its benchmark. Click here to uncover market drivers, policy shifts, and our strategic outlook.

A late-breaking presentation at the American Society of Hematology (ASH) 2025 meeting revealed promising phase 3 findings for ...

Tukysa added to Herceptin and Perjeta improved progression-free survival versus placebo in HER2-positive metastatic breast ...

Pirtobrutinib showed noninferiority in ORR compared to ibrutinib in BTK inhibitor-naive CLL/SLL patients, with a favorable PFS trend. Safety profiles indicated fewer adverse events with pirtobrutinib, ...

Among fit patients with acute myeloid leukemia, the combination of azacitidine plus Venclexta (venetoclax) was associated ...

Enterprises gain real-time visibility and control over post-signature obligations, helping reduce risk, enforce compliance, and accelerate business ...

Your home can feel cozy and personal while still looking current, but certain choices instantly age a space in photos and in ...